SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Attri, S
Right arrow Articles by Singh, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Attri, S
Right arrow Articles by Singh, K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Isoniazid – and rifampicin–induced oxidative hepatic injury – protection by N–acetylcysteine

S Attri

Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India; House No. 137, Sector 15-A, Chandigarh 160 015, India

S V Rana

Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

K Vaiphei

C P Sodhi

R Katyal

R C Goel

C K Nain

K Singh

Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

The role of N-acetylcysteine (NAC), a glutathione (GSH) precursor, was investigated in protection against isoniazid-(INH) and rifampicin-(RIF) induced oxidative hepatic injury in young Wistar rats. The hepatotoxic dose of INH and RIF was 50 mg kg-1 day-1 each and the hepatoprotective dose of NAC was 100 mg kgday-. All drugs were administered intraperitoneally (i.p.) in sterile water (4.0 ml kg-1 day-1) over a period of 3 weeks. Status of oxidative/antioxidative profiles was the mechanistic approach to assess the hepatotoxicity and/or hepatoprotection. The oxidative injury in INH-RIF co-exposed animals was closely associated with significant decline of GSH and related thiols, as well as with compromised antioxidant enzyme system. The oxidative stress was further supported by increased lipid peroxidation observed in these animals. The co-administration of NAC prevented the induction of oxidative stress in INH-RIF co-exposed animals. The amelioration of oxidative stress by NAC was faithfully reflected as normal morphology in these animals, except the presence of mild degree of portal triaditis in one animal co-exposed to INH-RIF and NAC. In contrast, the animals co-exposed to INH-RIF alone showed histological lesions which ranged from intralobular inflammation to patchy necrosis. These results suggest that INH-RIF-induced oxidative injury can be prevented by supporting the cellular antioxidant defense mechanism by NAC.

Key Words: hepatoprotection • isoniazid • N-acetylcysteine • oxidative stress • rifampicin

Human & Experimental Toxicology, Vol. 19, No. 9, 517-522 (2000)
DOI: 10.1191/096032700674230830


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
H. Yilmaz, E Uz, O Gokalp, N Ozcelik, E Cicek, and M. Ozer
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats
Toxicology and Industrial Health, September 1, 2008; 24(8): 519 - 524.
[Abstract] [PDF]



Advertisement